Evaluation of cell-mediated immune responses and bacterial clearance in 6-10 months old water buffalo (Bubalus bubalis) experimentally vaccinated with four dosages of commercial Brucella abortus strain RB51 vaccine

Veterinary Immunology and Immunopathology

Volumn 106, Issue 3-4, 2005, Pages 209-220

  Diptee, M D ^a   Adesiyun, A A ^a   Asgarali, Z ^a   Campbell, M ^a   Fosgate, G T ^b  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUCELLA VACCINE; EOSIN; GAMMA INTERFERON; HEMATOXYLIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRUCELLA ABORTUS; BRUCELLOSIS; BUFFALO; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MONONUCLEAR CELL; NONHUMAN; T LYMPHOCYTE; VACCINATION;

ANIMALS; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; BUFFALOES; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION SCHEDULE; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; MALE;

ANIMALIA; BRUCELLA MELITENSIS BIOVAR ABORTUS; BUBALUS BUBALIS;

EID: 20444482897     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2005.02.023     Document Type: Article

References (45)

1. L.G. Adams, R. Barthel, J.A. Gutiérrez, and J.W. Templeton Bovine natural resistance macrophage protein 1 (NRAMP1) gene Archiv Für Tierzucht 42 1999 42 54
2. A.A. Adesiyun, and E.P. Cazabon Seroprevalences of brucellosis. Q-fever and toxoplasmosis in slaughter livestock in Trinidad Rev. Elev. Med. Vet. Pays. Trop. 49 1996 28 30
3. L.N. Araya, P.H. Elzer, G.E. Rowe, F.M. Enright, and A.J. Winter Temporal development of protective cell mediated and humoral immunity in BALB/c mice infected with Brucella abortus J. Immunol. 143 10 1989 3330 3337
4. Z. Bercovich, and E.A. Ter Laak An evaluation of the DTH test for diagnosing brucellosis in individual cattle: a field study Vet. Microbiol. 22 2-3 1990 241 248
5. L. Blajan, and L.V. Melendez Contribution of the OIE to controlling animal brucellosison a world-wide scale Rev. Sci. Tech. 3 1984 167 189
6. N.F. Cheville, A.E. Jensen, S.M. Halling, F.M. Tatum, D.C. Morfitt, S.G. Hennager, W.M. Frerichs, and G.G. Schurig Bacterial survival, lymph node changes and immunologic responses of cattle vaccinated with standard and mutant strains of Brucella abortus Am. J. Vet. Res. 53 10 1992 1881 1888
7. N.F. Cheville, S.C. Olsen, A.E. Jensen, M.G. Stevens, M.V. Palmer, and A.M. Florance Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis Am. J. Vet. Res. 57 1996 1153 1156
8. M.J. Corbel Brucellosis: an overview Emerg. Infect. Dis. 3 1997 213 221
9. Diptee, M.D., 2004. Preliminary evaluation of the efficacy of Brucella abortus strain RB51 vaccine in domestic water buffalo (Bubalus bubalis). M.Phil. Thesis. University of the West Indies, St. Augustine, Trinidad, Tobago.
10. F.M. Enright The pathogenesis and pathobiology of Brucella infection on domestic animals K. Nielsenand J.R. Duncan Animal Brucellosis 1990 CRC Press Boca Raton, FL 301 320
11. G.T. Fosgate, A.A. Adesiyun, D.W. Hird, S.K. Hietala, and J. Ryan Isolation of Brucella abortus biovar 1 from cattle and water buffalo of Trinidad Vet. Rec. 151 2002 272 273
12. G.T. Fosgate, A.A. Adesiyun, D.W. Hird, W.O. Johnson, S.K. Hietala, G.G. Schurig, and J. Ryan Bayesian comparison of brucellosis serologic tests without a gold standard in cattle and water buffalo (Bubalus bubalis) of Trinidad Am. J. Vet. Res. 63 2002 1598 1605
13. G.T. Fosgate, A.A. Adesiyun, D.W. Hird, W.O. Johnson, S.K. Hietala, G.G. Schurig, J. Ryan, and M.D. Diptee Evaluation of brucellosis RB51 vaccine for domestic water buffalo (Bubalus bubalis) in Trinidad Prev. Vet. Med. 15 2003 211 225
14. A. Huda, P. Lind, A.B. Christoffersen, and G. Jungersen Analysis of repeated tests for interferon-gamma (IFN-gamma) response and faecal excretion for diagnosis of subclinical paratuberculosis in Danish cattle Vet. Immunol. Immunopathol. 94 3-4 2003 95 103
15. R. Kittelberger, M.P. Reichel, M.A. Joyce, and C. Staak Serological crossreactivity between Brucella abortus and Yersinia enterocolitica O:9. III. Specificity of the in vitro antigen-specific gamma interferon test for bovine brucellosis diagnosis in experimentally Yersinia enterocolitica 0:9-infected cattle Vet. Microbiol. 57 4 1997 361 371
16. R. Kittelberger, P.G. Bundesen, A. Cloeckaert, I. Greiser-Wilke, and J.J. Letesson Serological cross-reactivity between Brucella abortus and Yersinia enterocolitica O:9. IV. Evaluation of the M- and C-epitope antibody response for the specific detection of B. abortus infections Vet. Microbiol. 60 1 1998 45 57
17. T.J. Kreeger, M.W. Miller, M.A. Wild, P.H. Elzer, and S.C. Olsen Safety and efficacy of Brucella abortus strain RB51 vaccine in captive pregnant elk J. Wildl. Dis. 36 2000 477 483
18. T.J. Kreeger, W.E. Cook, W.H. Edwards, P.H. Elzer, and S.C. Olsen Brucella abortus strain RB51 vaccination in elk. II. Failure of high dosage to prevent abortion J. Wildl. Dis. 38 2002 27 31
19. V.R. Lord, G.G. Schurig, J.W. Cherwonogrodzky, M.J. Marcano, and G.E. Melendez Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low prevalence Am. J. Vet. Res. 59 1998 1016 1020
20. S.W. Martin The evaluation of tests Can. J. Comp. Med. 41 1997 19 25
21. V.P. Meador, L.B. Tabatabai, W.A. Hagemoser, and B.L. Deyoe Identification of Brucella abortus in formalin-fixed, paraffin-embedded tissues of cows, goats and mice with an avidin-biotin-peroxidase complex immunoenzymatic staining technique Am. J. Vet. Res. 47 10 1986 2147 2150
22. V.P. Meador, B.L. Deyoe, and N.F. Cheville Pathogenesis of Brucella abortus infection of the mammary gland and supramammary lymph node of the goat Vet. Pathol. 26 5 1989 357 368
23. R.N. Mohan Diseases and parasites of buffaloes Vet. Bull. 38 1968 647 659
24. Office International Des Epizooties (OIE), 2000. International Animal Health Code, 2.3.1, Accessed March 14, 2004. Available at: http://www.oie.int/.
25. S.C. Oliveira, and G.A. Splitter CD8+ type 1 CD44hi CD45 RB1o T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice Eur. J. Immunol. 25 1995 2551 2557
26. S.C. Oliveira, N. Soeurt, and G. Splitter Molecular and cellular interactions between Brucella abortus antigens and host immune responses Vet. Microbiol. 90 1-4 2002 417 424
27. S.C. Olsen, A.E. Jensen, and M.V. Palmer Evaluation of serologic responses, lymphocyte proliferative responses and clearance from lymphatic organs after vaccination of bison with Brucella abortus strain RB51 Am. J. Vet. Res. 59 4 1998 410 415
28. S.C. Olsen, B. Bricker, M.V. Palmer, and A.E. Jensen Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy Res. Vet. Sci. 66 1999 101 105
29. S.C. Olsen, J.C. Rhyan, T. Gidlewski, M.V. Palmer, and A.H. Jones Biosafety and antibody responses of adult bison bulls after vaccination with Brucella abortus strain RB51 Am. J. Vet. Res. 60 1999 905 908
30. S.C. Olsen Immune responses and efficacy after administration of a commercial Brucella abortus strain vaccine to cattle Vet. Therapeutics 1 2000 183 191
31. S.C. Olsen, T.J. Kreeger, and M.V. Palmer Immune responses of elk to vaccination with Brucella abortus strain RB51 J. Wildl. Dis. 38 2002 746 751
32. S.C. Olsen, A.E. Jensen, W.C. Stoffregen, and M.V. Palmer Efficacy of calfhood vaccination with Brucella abortus strain RB51 in protecting bison against brucellosis Res. Vet. Sci. 74 2003 17 22
33. M.V. Palmer, N.F. Cheville, and A.E. Jensen Experimental infection of pregnant cattle with the vaccine candidate Brucella abortus strain RB51: pathologic, bacteriologic and serologic findings Vet. Pathol. 33 6 1996 682 691
34. P. Pasquali, R. Adone, L.C. Gasbarre, C. Pistoia, and F. Ciuchini Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice Clin. Diagn. Lab. Immunol. 9 2 2002 491 492
35. C. Saegerman, T.K. Vo, L. De Waele, D. Gilson, A. Bastin, G. Dubray, P. Flanagan, J.N. Limet, J.J. Letesson, and J. Godfroid Diagnosis of bovine brucellosis by skin test: conditions for the test and evaluation of its performance Vet. Rec. 145 8 1999 214 218
36. G.G. Schurig, R.M. Roop II, T. Bagchi, S. Boyle, D. Buhrman, and N. Sriranganathan Biological properties of RB51; a stable rough strain of Brucella abortus Vet. Microbiol. 28 1991 171 188
37. M.M. Shafie Physiological responses and adaptation of water buffalo M.K. Yousef Stress Physiology in Livestock, Ungulates vol. 2 1985 CRC Press Florida, USA
38. R.D. Smith Veterinary Clinical Epidemiology 1991 Butterworths-Heinemann Woburn, MA 234
39. M.G. Stevens, S.G. Hennager, S.C. Olsen, and N.F. Cheville Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51 J. Clin. Microbiol. 32 1994 1065 1066
40. M.G. Stevens, Olsen, and N.F. Cheville Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or strain RB51 Vet. Immunol. Immunopathol. 44 3-4 1995 223 235
41. M.G. Stevens, S.C. Olsen, M.V. Palmer, and N.F. Cheville Brucella abortus strain RB51: a new brucellosis vaccine for cattle Compend. Continuing Edu. Pract. Veterinarian 19 1997 766 774
42. V. Weynants, J. Godfroid, B. Limbourg, C. Saegerman, and J.J. Letesson Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production J. Clin. Microbiol. 33 3 1995 706 712
43. V. Weynants, K. Walravens, C. Didembourg, P. Flanagan, J. Godfroid, and J.J. Letesson Quantitative assessment by flow cytometry of T-lymphocytes producing antigen-specific gamma-interferon in Brucella immune cattle Vet. Immunol. Immunopathol. 66 3-4 1998 309 320
44. E.J. Young An overview of human brucellosis Clin. Infect. Dis. 5 1995 283 290
45. Y. Zhan, Z. Liu, and C. Cheers Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms Infect. Immun. 64 1996 2782 2786